Ozanimod T6923
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ozanimod (RPC1063) is a specific oral S1P Receptor 1 modulator. Ozanimod has been used in trials studying the treatment of Crohn's Disease, Ulcerative Colitis, Multiple Sclerosis, and Relapsing Multiple Sclerosis.
CAS nr:
1306760-87-1
Purity:
98%
Molecular Weight:
404,46
SMILES:
C(#N)c1c(ccc(c1)c1onc(n1)c1c2CC[C@@H](c2ccc1)NCCO)OC(C)C
Formula:
C23H24N4O3
Pathway:
GPCR/G Protein,GPCR/G Protein
Target:
LPL Receptor,S1P Receptor
